CIBC World Markets’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $10.9M | Buy |
+31,016
| New | +$10.5M | 0.05% | 231 |
|
|
2025
Q2 | $11.1M | Buy |
28,450
+475
| +2% | +$191K | 0.07% | 224 |
|
|
2025
Q1 | $12.2M | Sell |
27,975
-8,595
| -24% | -$3.45M | 0.1% | 153 |
|
|
2024
Q4 | $13.5M | Buy |
36,570
+5,035
| +16% | +$2.11M | 0.08% | 186 |
|
|
2024
Q3 | $16.4M | Buy |
31,535
+1,554
| +5% | +$830K | 0.12% | 142 |
|
|
2024
Q2 | $16.2M | Buy |
29,981
+6,453
| +27% | +$3.41M | 0.11% | 138 |
|
|
2024
Q1 | $12.2M | Sell |
23,528
-55,865
| -70% | -$27.8M | 0.08% | 165 |
|
|
2023
Q4 | $37.4M | Buy |
79,393
+51,387
| +183% | +$23.8M | 0.2% | 77 |
|
|
2023
Q3 | $12.2M | Buy |
28,006
+233
| +0.8% | +$106K | 0.12% | 132 |
|
|
2023
Q2 | $12.3M | Sell |
27,773
-7,968
| -22% | -$3.68M | 0.1% | 155 |
|
|
2023
Q1 | $16.4M | Buy |
35,741
+3,863
| +12% | +$1.84M | 0.27% | 78 |
|
|
2022
Q4 | $16.4M | Sell |
31,878
-205,818
| -87% | -$105M | 0.11% | 136 |
|
|
2022
Q3 | $108M | Sell |
237,696
-88,534
| -27% | -$42.4M | 1.5% | 10 |
|
|
2022
Q2 | $157M | Sell |
326,230
-33,101
| -9% | -$16.4M | 1.48% | 10 |
|
|
2022
Q1 | $177M | Sell |
359,331
-11,843
| -3% | -$5.41M | 1.38% | 9 |
|
|
2021
Q4 | $172M | Buy |
371,174
+316,160
| +575% | +$133M | 0.92% | 22 |
|
|
2021
Q3 | $20.5M | Buy |
55,014
+38,014
| +224% | +$14.4M | 0.14% | 110 |
|
|
2021
Q2 | $6.49M | Sell |
17,000
-6,347
| -27% | -$2.43M | 0.05% | 221 |
|
|
2021
Q1 | $8.38M | Sell |
23,347
-26,179
| -53% | -$8.42M | 0.05% | 210 |
|
|
2020
Q4 | $15.9M | Buy |
49,526
+19,241
| +64% | +$5.9M | 0.08% | 175 |
|
|
2020
Q3 | $8.13M | Buy |
30,285
+5,530
| +22% | +$1.49M | 0.08% | 231 |
|
|
2020
Q2 | $6.51M | Buy |
24,755
+6,197
| +33% | +$1.65M | 0.07% | 214 |
|
|
2020
Q1 | $4.21M | Sell |
18,558
-90,431
| -83% | -$24.6M | 0.05% | 232 |
|
|
2019
Q4 | $32.9M | Buy |
108,989
+16,986
| +18% | +$4.67M | 0.21% | 109 |
|
|
2019
Q3 | $22.1M | Buy |
92,003
+33,235
| +57% | +$9.11M | 0.21% | 123 |
|
|
2019
Q2 | $16.6M | Sell |
58,768
-2,754
| -4% | -$752K | 0.13% | 180 |
|
|
2019
Q1 | $17.7M | Sell |
61,522
-162,363
| -73% | -$47M | 0.14% | 151 |
|
|
2018
Q4 | $58.8M | Buy |
223,885
+106,206
| +90% | +$29.2M | 0.55% | 42 |
|
|
2018
Q3 | $32.3M | Buy |
117,679
+43,363
| +58% | +$11.3M | 0.28% | 94 |
|
|
2018
Q2 | $17.7M | Buy |
74,316
+26,912
| +57% | +$6.23M | 0.15% | 166 |
|
|
2018
Q1 | $10.4M | Sell |
47,404
-9,873
| -17% | -$2.32M | 0.11% | 176 |
|
|
2017
Q4 | $12.9M | Sell |
57,277
-63,139
| -52% | -$13.4M | 0.09% | 178 |
|
|
2017
Q3 | $22.9M | Sell |
120,416
-151,596
| -56% | -$28.9M | 0.22% | 99 |
|
|
2017
Q2 | $51.2M | Buy |
272,012
+150,816
| +124% | +$27.1M | 0.54% | 42 |
|
|
2017
Q1 | $20M | Buy |
121,196
+103,084
| +569% | +$16.4M | 0.16% | 110 |
|
|
2016
Q4 | $2.6M | Buy |
+18,112
| New | +$2.43M | 0.03% | 269 |
|
Other funds holding ELV
CIBC World Markets's ELV Position: Q4 2025 in Review
CIBC World Markets opened a new position in Elevance Health (ELV) in Q4 2025: 31,016 shares worth $10.9M. The stake represents 0.05% of the portfolio and ranks #231 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in ELV as recently as Q2 2025.
CIBC World Markets first reported a position in ELV in Q4 2016 and has held it in 36 quarters since. The position peaked at $177M in Q1 2022. 1,553 funds tracked by Wall St. Rank hold ELV as of Q4 2025.
- CIBC World Markets held 31,016 shares of Elevance Health worth $10.9M as of Q4 2025.
- Elevance Health was a new CIBC World Markets position in Q4 2025.
- Elevance Health made up 0.05% of CIBC World Markets's portfolio in Q4 2025, its #231 holding.
- CIBC World Markets first reported a position in Elevance Health in Q4 2016 and has held it in 36 quarters since.
- CIBC World Markets's Elevance Health position peaked at $177M in Q1 2022.
- 1,553 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.
Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.